Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07330492 · ClinicalTrials.gov registry record · NA
Testing a Brief Reassurance Message Before a Musculoskeletal Clinic Visit
A NA study, sponsored by University of Texas at Austin.
- Active
- Registry status
- NA
- Development phase
- 144
- Enrollment target
NCT07330492: Active NA study, sponsored by University of Texas at Austin.
NCT07330492 is a NA study that is active but no longer recruiting, run by University of Texas at Austin. The registered enrollment target is 144 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07330492, a NA study, is active but no longer recruiting, sponsored by University of Texas at Austin.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a brief, reassuring pre-visit message affects patients' expectations and planned follow-up care in adults with common musculoskeletal conditions. The main questions it aims to answer are: * Does reading a brief reassurance message before a clinic visit change how interested patients are in additional care, such as follow-up visits, tests, injections, or surgery? * Does the message affect whether patients actually schedule follow-up care after the visit? Researchers will compare participants who receive the pre-visit reassurance message to those who receive usual care to see if the message changes patients' enthusiasm for care or their follow-up decisions. Participants will: 1. Read a short, easy-to-understand message about musculoskeletal symptoms and options for care (for those in the intervention group) 2. Complete a brief questionnaire rating their interest in follow-up visits, tests, injections, or surgery 3. Have their scheduled follow-up care recorded after the clinic visit
Primary Outcome
The primary outcome is pre-visit enthusiasm for additional care, measured as participants' self-reported interest in pursuing a return visit, diagnostic tests, physical therapy, injections, or surgery. Participants rate each item on a 0-10 scale, where 0 indicates "not at all interested" and 10 indicates "definitely want it." This outcome is assessed immediately after the intervention (or usual care) and before the clinic visit.
Interventions
- BEHAVIORAL Nudge intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2026-01-10 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What the registry record for NCT07330492 still lists
NCT07330492 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Nudge intervention is the first listed.
NCT07330492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07330492 about?
NCT07330492 is a clinical study titled "Testing a Brief Reassurance Message Before a Musculoskeletal Clinic Visit". The goal of this clinical trial is to learn if a brief, reassuring pre-visit message affects patients' expectations and planned follow-up care in adults with common musculoskeletal conditions. The main questions it aims to answer are: * Does reading a brief reassurance message before a clinic visit...
What is the current status of trial NCT07330492?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2026-01-10. Estimated completion is 2026-07-31.
What interventions are being tested in trial NCT07330492?
The interventions under investigation include: Nudge intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07330492?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07330492's enrollment target sits among peer trials
144 706th of 2000 higher than 1,290 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI